Spyke
news·NewsbySalamendacious

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors

Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas.

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumorshttps://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-type-non-cancerous-tumorsOpen linkView original on lemmy.world
43
Comments
No comments on the original post yet.
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors | Spyke